BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30414531)

  • 1. Identification of a somatic mutation in the RHEB gene through high depth and ultra-high depth next generation sequencing in a patient with Hemimegalencephaly and drug resistant Epilepsy.
    Salinas V; Vega P; Piccirilli MV; Chicco C; Ciraolo C; Christiansen S; Consalvo D; Perez-Maturo J; Medina N; González-Morón D; Novaro V; Perrone C; García MDC; Agosta G; Silva W; Kauffman M
    Eur J Med Genet; 2019 Nov; 62(11):103571. PubMed ID: 30414531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradient of brain mosaic RHEB variants causes a continuum of cortical dysplasia.
    Lee WS; Baldassari S; Chipaux M; Adle-Biassette H; Stephenson SEM; Maixner W; Harvey AS; Lockhart PJ; Baulac S; Leventer RJ
    Ann Clin Transl Neurol; 2021 Feb; 8(2):485-490. PubMed ID: 33434304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
    Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
    Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
    Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
    Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
    Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
    Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case Report.
    Xu Q; Uliel-Sibony S; Dunham C; Sarnat H; Flores-Sarnat L; Brunga L; Davidson S; Lo W; Shlien A; Connolly M; Boelman C; Datta A
    J Child Neurol; 2019 Mar; 34(3):132-138. PubMed ID: 30514132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
    Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
    Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
    Zhao S; Li Z; Zhang M; Zhang L; Zheng H; Ning J; Wang Y; Wang F; Zhang X; Gan H; Wang Y; Zhang X; Luo H; Bu G; Xu H; Yao Y; Zhang YW
    Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31337748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
    D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
    Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic Active mTOR Mutation in Brain Malformation with Intractable Epilepsy Leads to Cell-Autonomous Migration Delay.
    Hanai S; Sukigara S; Dai H; Owa T; Horike SI; Otsuki T; Saito T; Nakagawa E; Ikegaya N; Kaido T; Sato N; Takahashi A; Sugai K; Saito Y; Sasaki M; Hoshino M; Goto YI; Koizumi S; Itoh M
    Am J Pathol; 2017 May; 187(5):1177-1185. PubMed ID: 28427592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
    Gerasimenko A; Baldassari S; Baulac S
    Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA.
    Lee WS; Stephenson SEM; Howell KB; Pope K; Gillies G; Wray A; Maixner W; Mandelstam SA; Berkovic SF; Scheffer IE; MacGregor D; Harvey AS; Lockhart PJ; Leventer RJ
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1338-1344. PubMed ID: 31353856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical Dyslamination.
    Park SM; Lim JS; Ramakrishina S; Kim SH; Kim WK; Lee J; Kang HC; Reiter JF; Kim DS; Kim HH; Lee JH
    Neuron; 2018 Jul; 99(1):83-97.e7. PubMed ID: 29937275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technological and computational approaches to detect somatic mosaicism in epilepsy.
    Boßelmann CM; Leu C; Lal D
    Neurobiol Dis; 2023 Aug; 184():106208. PubMed ID: 37343892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Cortical Dysplasia.
    Crino PB
    Semin Neurol; 2015 Jun; 35(3):201-8. PubMed ID: 26060899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.